Early Body-Composition Trajectory During Tirzepatide Treatment for Obesity: A Real-World Bioimpedance Cohort Study
Background/Objectives: Whether the loss of fat-free mass (FFM) during tirzepatide treatment exceeds the proportion expected in negative energy balance is debated, and the earliest weeks of treatment are the least characterized. We described the body-composition trajectory over the first 12 weeks of treatment in routine...